NCT04619433 2025-09-23
A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Terminated
Clinical Trials
5 trialsNCT05258279 2024-08-28
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
Juntendo University
Phase 2 Active not recruiting
NCT05849246 2024-08-20
The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2 Terminated
NCT05318443 2023-12-27
A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer
Shanghai Institute Of Biological Products
Phase 3 Completed
NCT04012619 2023-08-03
Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer
Sichuan University
Phase 1 Completed